Jilin Aodong Pharmaceutical Group Co Ltd (000623) - Total Liabilities
Based on the latest financial reports, Jilin Aodong Pharmaceutical Group Co Ltd (000623) has total liabilities worth CN¥3.55 Billion CNY (≈ $519.98 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Jilin Aodong Pharmaceutical Group Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Jilin Aodong Pharmaceutical Group Co Ltd - Total Liabilities Trend (1993–2025)
This chart illustrates how Jilin Aodong Pharmaceutical Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Jilin Aodong Pharmaceutical Group Co Ltd.
Jilin Aodong Pharmaceutical Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jilin Aodong Pharmaceutical Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hybio Pharmaceutical
SHE:300199
|
China | CN¥2.50 Billion |
|
Huada Automotive Tech Corp Ltd
SHG:603358
|
China | CN¥3.90 Billion |
|
Maximus Inc
NYSE:MMS
|
USA | $2.63 Billion |
|
Mr D I Y Group M Bhd
KLSE:5296
|
Malaysia | RM2.41 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥3.17 Billion |
|
FS KKR Capital Corp
NYSE:FSK
|
USA | $7.55 Billion |
|
PENNON GROUP PLC UNS.ADR2
F:3PN0
|
Germany | €6.02 Billion |
|
Provident Financial Services Inc
NYSE:PFS
|
USA | $22.76 Billion |
Liability Composition Analysis (1993–2025)
This chart breaks down Jilin Aodong Pharmaceutical Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See 000623 equity financing ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.38 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jilin Aodong Pharmaceutical Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jilin Aodong Pharmaceutical Group Co Ltd (1993–2025)
The table below shows the annual total liabilities of Jilin Aodong Pharmaceutical Group Co Ltd from 1993 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥3.53 Billion ≈ $516.69 Million |
-5.07% |
| 2024-12-31 | CN¥3.72 Billion ≈ $544.30 Million |
-21.96% |
| 2023-12-31 | CN¥4.77 Billion ≈ $697.49 Million |
-1.60% |
| 2022-12-31 | CN¥4.84 Billion ≈ $708.82 Million |
+20.24% |
| 2021-12-31 | CN¥4.03 Billion ≈ $589.52 Million |
+3.91% |
| 2020-12-31 | CN¥3.88 Billion ≈ $567.32 Million |
+15.51% |
| 2019-12-31 | CN¥3.36 Billion ≈ $491.12 Million |
-1.70% |
| 2018-12-31 | CN¥3.41 Billion ≈ $499.60 Million |
+159.05% |
| 2017-12-31 | CN¥1.32 Billion ≈ $192.86 Million |
-10.13% |
| 2016-12-31 | CN¥1.47 Billion ≈ $214.59 Million |
-34.84% |
| 2015-12-31 | CN¥2.25 Billion ≈ $329.31 Million |
+102.65% |
| 2014-12-31 | CN¥1.11 Billion ≈ $162.50 Million |
+10.38% |
| 2013-12-31 | CN¥1.01 Billion ≈ $147.21 Million |
-16.72% |
| 2012-12-31 | CN¥1.21 Billion ≈ $176.78 Million |
+22.54% |
| 2011-12-31 | CN¥985.86 Million ≈ $144.26 Million |
+51.11% |
| 2010-12-31 | CN¥652.43 Million ≈ $95.47 Million |
+8.41% |
| 2009-12-31 | CN¥601.83 Million ≈ $88.07 Million |
-5.18% |
| 2008-12-31 | CN¥634.74 Million ≈ $92.88 Million |
-14.79% |
| 2007-12-31 | CN¥744.94 Million ≈ $109.01 Million |
-21.11% |
| 2006-12-31 | CN¥944.28 Million ≈ $138.18 Million |
+13.79% |
| 2005-12-31 | CN¥829.84 Million ≈ $121.43 Million |
-6.77% |
| 2004-12-31 | CN¥890.13 Million ≈ $130.25 Million |
+48.31% |
| 2003-12-31 | CN¥600.19 Million ≈ $87.83 Million |
-1.60% |
| 2002-12-31 | CN¥609.94 Million ≈ $89.25 Million |
+18.99% |
| 2001-12-31 | CN¥512.58 Million ≈ $75.01 Million |
+57.61% |
| 2000-12-31 | CN¥325.23 Million ≈ $47.59 Million |
-30.03% |
| 1999-12-31 | CN¥464.78 Million ≈ $68.01 Million |
+118.80% |
| 1998-12-31 | CN¥212.43 Million ≈ $31.08 Million |
-5.81% |
| 1997-12-31 | CN¥225.52 Million ≈ $33.00 Million |
+26.44% |
| 1996-12-31 | CN¥178.36 Million ≈ $26.10 Million |
+23.63% |
| 1995-12-31 | CN¥144.27 Million ≈ $21.11 Million |
+6.66% |
| 1994-12-31 | CN¥135.27 Million ≈ $19.79 Million |
+15.88% |
| 1993-12-31 | CN¥116.73 Million ≈ $17.08 Million |
-- |
About Jilin Aodong Pharmaceutical Group Co Ltd
Jilin Aodong Pharmaceutical Group Co., Ltd. manufactures and sells pharmaceutical products in China. It provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction … Read more